ResoundingHealth
Search
  
Basic Drug Info
Drug Name:Dextrose and Sodium Chloride
Manufacturer:Hospira, Inc.
Other Info:

To Open:Tear outer wrap at notch and remove solution container.

If supplemental medication is desired, follow directions below before preparing for administration.To Add MedicationPrepare additive port.Using aseptic technique and an additive delivery needle of appropriate length, puncture resealable additive port at target area, inner diaphragm and inject.

Withdraw needle after injecting medication.The additive port may be protected by covering with an additive cap.Mix container contents thoroughly.Preparation for Administration(Use aseptic technique)Close flow control clamp of administration set.Remove cover from outlet port at bottom of container.Insert piercing pin of administration set into port with a twisting motion until the set is firmly seated.

NOTE: When using a vented administration set, replace bacterial retentive air filter with piercing pin cover.

Insert piercing pin with twisting motion until shoulder of air filter housing rests against the outlet port flange.Suspend container from hanger.Squeeze and release drip chamber to establish proper fluid level in chamber.Attach venipuncture device to set.Open clamp to expel air from set and venipuncture device. Close clamp.Perform venipuncture.Regulate rate of administration with flow control clamp.WARNING: Do not use flexible container in series connections.



Clinical Trials:


Indications and Usage
Intravenous solutions containing dextrose and sodium chloride are indicated for parenteral replenishment of fluid, minimal carbohydrate calories, and sodium chloride as required by the clinical condition of the patient.
Contraindications
None known.
Warnings

Solutions containing sodium ions should be used with great care, if at all, in patients with congestive heart failure, severe renal insufficiency and in clinical states in which there exists edema with sodium retention.Excessive administration of potassium-free solutions may result in significant hypokalemia.In patients with diminished renal function, administration of solutions containing sodium ions may result in sodium retention.The intravenous administration of these solutions can cause fluid and/or solute overloading resulting in dilution of serum electrolyte concentrations, overhydration, congested states or pulmonary edema.The risk of dilutional states is inversely proportional to the electrolyte concentrations of administered parenteral solutions.

The risk of solute overload causing congested states with peripheral and pulmonary edema is directly proportional to the electrolyte concentrations of such solutions.

This web-site is for informational purposes only and is not intended as a substitute for advice from your doctor. It should not to be used for self-diagnosis or treatment.